SNAI1 and nasopharyngeal carcinoma: LINC00511 and EBV-miR-Bart10-3p both inhibit β-TrCP1 and prevent Snail1 degradation in triple negative breast cancer and nasopharyngeal carcinoma, respectively (87, 88).